Literature DB >> 25737556

Quorum-sensing Salmonella selectively trigger protein expression within tumors.

Charles A Swofford1, Nele Van Dessel1, Neil S Forbes2.   

Abstract

Salmonella that secrete anticancer proteins have the potential to eliminate tumors, but nonspecific expression causes damage to healthy tissue. We hypothesize that Salmonella, integrated with a density-dependent switch, would only express proteins in tightly packed colonies within tumors. To test this hypothesis, we cloned the lux quorum-sensing (QS) system and a GFP reporter into nonpathogenic Salmonella. Fluorescence and bacterial density were measured in culture and in a tumor-on-a-chip device to determine the critical density necessary to initiate expression. QS Salmonella were injected into 4T1 tumor-bearing mice to quantify GFP expression in vivo using immunofluorescence. At densities below 0.6 × 10(10) cfu/g in tumors, less than 3% of QS Salmonella expressed GFP. Above densities of 4.2 × 10(10) cfu/g, QS Salmonella had similar expression levels to constitutive controls. GFP expression by QS colonies was dependent upon the distance to neighboring bacteria. No colonies expressed GFP when the average distance to neighbors was greater than 155 µm. Calculations of autoinducer concentrations showed that expression was sigmoidally dependent on density and inversely dependent on average radial distance. Based on bacterial counts from excised tissue, the liver density (0.0079 × 10(10) cfu/g) was less than the critical density (0.11 × 10(10) cfu/g) necessary to initiate expression. QS Salmonella are a promising tool for cancer treatment that will target drugs to tumors while preventing damage to healthy tissue.

Entities:  

Keywords:  Salmonella; bacterial anticancer therapy; cancer; localized drug delivery; quorum sensing

Mesh:

Substances:

Year:  2015        PMID: 25737556      PMCID: PMC4371937          DOI: 10.1073/pnas.1414558112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Microfluidic device for recreating a tumor microenvironment in vitro.

Authors:  Bhushan J Toley; Dan E Ganz; Colin L Walsh; Neil S Forbes
Journal:  J Vis Exp       Date:  2011-11-20       Impact factor: 1.355

2.  Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

Authors:  Bhushan J Toley; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2011-12-22       Impact factor: 2.192

3.  Development of hypoxia in a preclinical model of tumor micrometastases.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Einar K Rofstad
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

4.  Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.

Authors:  R M Ryan; J Green; P J Williams; S Tazzyman; S Hunt; J H Harmey; S C Kehoe; C E Lewis
Journal:  Gene Ther       Date:  2009-01-29       Impact factor: 5.250

5.  IL-18-producing Salmonella inhibit tumor growth.

Authors:  M Loeffler; G Le'Negrate; M Krajewska; J C Reed
Journal:  Cancer Gene Ther       Date:  2008-07-25       Impact factor: 5.987

Review 6.  Quorum sensing and the confusion about diffusion.

Authors:  Stuart A West; Klaus Winzer; Andy Gardner; Stephen P Diggle
Journal:  Trends Microbiol       Date:  2012-10-18       Impact factor: 17.079

7.  Salmonella promoters preferentially activated inside tumors.

Authors:  Nabil Arrach; Ming Zhao; Steffen Porwollik; Robert M Hoffman; Michael McClelland
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

8.  A systems approach for tumor pharmacokinetics.

Authors:  Greg Michael Thurber; Ralph Weissleder
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

9.  In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis.

Authors:  S Ganai; R B Arenas; J P Sauer; B Bentley; N S Forbes
Journal:  Cancer Gene Ther       Date:  2011-03-25       Impact factor: 5.987

10.  Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.

Authors:  S Ganai; R B Arenas; N S Forbes
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

View more
  29 in total

1.  Advances in bacterial cancer therapies using synthetic biology.

Authors:  Tiffany Chien; Anjali Doshi; Tal Danino
Journal:  Curr Opin Syst Biol       Date:  2017-05-23

Review 2.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

3.  Directed assembly of a bacterial quorum.

Authors:  Matthew D Servinsky; Jessica L Terrell; Chen-Yu Tsao; Hsuan-Chen Wu; David N Quan; Amin Zargar; Patrick C Allen; Christopher M Byrd; Christian J Sund; William E Bentley
Journal:  ISME J       Date:  2015-06-05       Impact factor: 10.302

4.  Homologous Quorum Sensing Regulatory Circuit: A Dual-Input Genetic Controller for Modulating Quorum Sensing-Mediated Protein Expression in E. coli.

Authors:  Pricila Hauk; Kristina Stephens; Chelsea Virgile; Eric VanArsdale; Alex Eli Pottash; John S Schardt; Steven M Jay; Herman O Sintim; William E Bentley
Journal:  ACS Synth Biol       Date:  2020-09-15       Impact factor: 5.110

Review 5.  Engineering bacteria for diagnostic and therapeutic applications.

Authors:  David T Riglar; Pamela A Silver
Journal:  Nat Rev Microbiol       Date:  2018-02-05       Impact factor: 60.633

6.  Engineering bacteria for cancer therapy.

Authors:  Tetsuhiro Harimoto; Tal Danino
Journal:  Emerg Top Life Sci       Date:  2019-11-11

7.  Rapid screening of engineered microbial therapies in a 3D multicellular model.

Authors:  Tetsuhiro Harimoto; Zakary S Singer; Oscar S Velazquez; Joanna Zhang; Samuel Castro; Taylor E Hinchliffe; William Mather; Tal Danino
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-17       Impact factor: 11.205

8.  Programmable probiotics for detection of cancer in urine.

Authors:  Tal Danino; Arthur Prindle; Gabriel A Kwong; Matthew Skalak; Howard Li; Kaitlin Allen; Jeff Hasty; Sangeeta N Bhatia
Journal:  Sci Transl Med       Date:  2015-05-27       Impact factor: 17.956

Review 9.  Engineering the gut microbiota to treat chronic diseases.

Authors:  Noura S Dosoky; Linda S May-Zhang; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2020-07-21       Impact factor: 4.813

Review 10.  The microbiome and human cancer.

Authors:  Gregory D Sepich-Poore; Laurence Zitvogel; Ravid Straussman; Jeff Hasty; Jennifer A Wargo; Rob Knight
Journal:  Science       Date:  2021-03-26       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.